Clinical Trial Update: Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating chemotherapy combined with pembrolizumab for thymoma and thymic carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Thymoma and Thymic Carcinoma | Phase 4 | Status: UNKNOWN